× Important note: Due to the end of funding, these reviews are no longer in living mode. We try to update them on a monthly basis.

meta|Evidence - COVID-19

Living meta-analysis and evidence synthesis of therapies for COVID19  

Member of the meta|Evidence galaxy

tutorial video
En     Fr

Our approach

RSS

       
button bars forest bayes pooled summary circles
Treament Trials   auto
deathsclinical improvementdeath or ventilation
0---
0---
3 0.64 [0.21; 1.98], 2 RCTs, I2=0%
inconclusive result		 1.38 [0.98; 1.95], 2 RCTs, I2=30%
inconclusive result		-
1 / 2 0.50 [0.09; 2.71], 1 RCT, I2=0%
inconclusive result		--
0 / 2 ---
0---
0 / 1 --
1 0.61 [0.41; 0.92], 1 RCT, I2=0%
unassessable degree of certainty		- 0.66 [0.46; 0.94], 1 RCT, I2=0%
unassessable degree of certainty
4 1.91 [0.24; 15.30], 3 RCTs, I2=0%
inconclusive result		 0.68 [0.21; 2.20], 1 RCT, I2=0%
inconclusive result		-
0 / 1 ---
0---
1 0.88 [0.64; 1.20], 1 RCT, I2=0%
inconclusive result		- 0.82 [0.63; 1.07], 1 RCT, I2=0%
inconclusive result
0---

Statistically conclusive: statistically significant with a strict control of overall risk of type 1 error (statistically demonstrated), does not take into account the risk of bias; suggested: nominally statistically significant but without a strict control of overall risk of type 1 error; inconclusive: not nominally statistically significant

149
treatments 		  718
studies with results 		  1743
studies screend 		  1629
references

This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N), Université de Lyon (UdL/Idex), and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.

     

- About - Our approach - Credits - RSS Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons